Sunshine Biopharma, Inc
SBFM, SBFMWOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $36.3M | $34.9M | $24.1M | $4.3M | $228,426 | $71,410 |
| Operating income | −$6.2M | −$5.8M | −$4.8M | −$27.0M | −$2.4M | −$576,874 |
| Net income | −$6.0M | −$5.1M | −$4.5M | −$26.7M | −$12.4M | −$2.8M |
| Total assets | $30.1M | $30.6M | $27.3M | $29.2M | $2.2M | $1.0M |
| Total liabilities | $7.0M | $7.1M | $6.1M | $7.6M | $2.0M | $2.0M |
| Equity | $23.0M | $23.5M | $21.2M | $21.6M | $211,662 | −$954,837 |
| EPS (diluted) | $-1.44 | $-7.32 | $-351.36 | $-1.76 | $-4.76 | $-2.73 |
| Shares out. | 2.7M | 99.5M | 22.6M | 7.1M | 465.0M | 69.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −17.2%
- Net margin
- −16.5%
- Return on equity
- −25.9%
- Return on assets
- −19.9%
- Return on capital (ROCE)
- −26.3%
- Liabilities / assets
- 23.4%
- Debt / equity
- 0.31×
- Book value / share
- $8.51
- Revenue growth (YoY)
- 4.1%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.63distress
- Accruals / assets
- −2.1%clean
- Beneish M-Score
- -2.90normal
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2026
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2025
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 31, 2023
- NT 10-Qmissed a reporting deadline ↗Aug 14, 2020
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- L1 Capital Global Opportunities Master Fund, Ltd.Passive (13G)May 22, 2026
- Bigger Capital Fund L PPassive (13G)May 21, 2026
- Altium Capital Management LlcPassive (13G)Aug 14, 2025
- Intracoastal Capital, LlcPassive (13G)May 23, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Natan DavidDirector | Apr 14, 2026 | Grant | 100,000 | $0.00 |
| Slilaty Steve N.Officer — Chief Executive Officer | Mar 4, 2024 | Buy | 100,000 | $0.10 |
| Slilaty Steve N.Officer — Chief Executive Officer | Feb 8, 2024 | Buy | 20,000 | $0.10 |
| Sebaaly CamilleOfficer — CFO/Secretary | Nov 30, 2022 | Buy | 30,000 | $0.76 |
| Sebaaly CamilleOfficer — CFO/Secretary | Jun 3, 2022 | Buy | 25,000 | $1.22 |
| Slilaty Steve N.Officer — Chief Executive Officer | Feb 18, 2022 | D | 990,000 | $0.10 |
| Merzouki AbderrazzakOfficer — Chief Operating Officer | Jan 6, 2021 | Grant | 20.0M | $0.00 |
| Slilaty Steve N.Officer — Chief Executive Officer | Jan 6, 2021 | Grant | 20.0M | $0.00 |
| Sebaaly CamilleOfficer — CFO/Secretary | Jan 6, 2021 | Grant | 20.0M | $0.00 |
| Sebaaly CamilleOfficer — CFO/Secretary | Sep 11, 2019 | Grant | 550,000 | $0.00 |
| Merzouki AbderrazzakOfficer — Chief Operating Officer | Oct 20, 2019 | Grant | 1.1M | $0.00 |
| Slilaty Steve N.Officer — Chief Executive Officer | Oct 20, 2019 | Grant | 1.1M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 29, 2026
- Entered a material agreement · Other material eventMay 19, 2026
- Results of operationsApr 9, 2026
- Other material eventMar 9, 2026
- Shareholder voteFeb 20, 2026
- Director / officer changeFeb 5, 2026
- Shareholder voteDec 12, 2025
- Changed auditorSep 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- PRE 14CPRELIMINARY INFORMATION STATEMENTMay 29, 2026
- 8-KCURRENT REPORTMay 29, 2026
- SCHEDULE 13GMay 22, 2026
- SCHEDULE 13GMay 21, 2026
- 8-KCURRENT REPORTMay 19, 2026
- 424B4PROSPECTUSMay 19, 2026
- EFFECTMay 18, 2026
- 10-QFORM 10-Q FOR MAR 2026May 13, 2026
- S-1FORM S-1May 12, 2026
- DRSApr 28, 2026
- 4Apr 14, 2026
- 8-KCURRENT REPORTApr 9, 2026
- 10-KFORM 10-K FOR DEC 2025Apr 3, 2026
- NT 10-KEXTENSIONMar 31, 2026
- 8-KFORM 8-KMar 9, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.